TLDR Morgan Stanley cut Kering to “equal-weight” from “overweight,” lowering its price target to €320 from €330. The stock fell over 3% on Monday following theTLDR Morgan Stanley cut Kering to “equal-weight” from “overweight,” lowering its price target to €320 from €330. The stock fell over 3% on Monday following the

Kering (PRTP) Stock Falls 3% as Morgan Stanley’s Patience With Gucci Runs Out

2026/04/13 20:33
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Morgan Stanley cut Kering to “equal-weight” from “overweight,” lowering its price target to €320 from €330.
  • The stock fell over 3% on Monday following the downgrade.
  • The bank cited limited upside after a strong year-to-date run, saying the outperformance is now “priced in.”
  • Gucci, Kering’s flagship brand, is forecast to see sales decline 6.2% in Q1 2026 — worse than prior estimates.
  • The downgrade lands days before Kering’s Q1 2026 revenue update on April 14 and a Capital Markets Day on April 16.

Kering stock took a hit on Monday after Morgan Stanley pulled back its positive outlook on the French luxury group, downgrading it just days ahead of key earnings events.


PPX.DE Stock Card
Kering S.A., PPX.DE

The bank moved its rating from “overweight” to “equal-weight” and trimmed its 12-to-18-month price target from €330 to €320. The stock fell more than 3% on the news.

Morgan Stanley’s reasoning was straightforward: Kering had a strong run, outperforming rivals LVMH, Hermès, and Richemont by 300 to 1,700 basis points since the start of the year. That rally, the bank said, has eaten up most of the available upside.

The stock hit a year-to-date high of €320.50 on January 12, then slid roughly 16% through Monday. It had surged 10.90% on February 10 — its biggest single-day gain in the period — only to give back much of that in a sharp two-day drop of 5.04% and 6.35% on March 2 and 3.

Gucci Still the Sticking Point

Gucci remains the central concern. Morgan Stanley now models the brand declining 6.2% in Q1 2026, worse than its prior estimate of a 5% drop. For the full year 2026, Gucci is forecast to generate €5.95 billion in revenue, rising to €7.67 billion by 2028.

The weaker outlook was also shaped by softer Q1 channel checks and Kering’s exposure to the Middle East conflict, which accounts for roughly 5% of total sales.

Timing and What Comes Next

The downgrade lands at a sensitive moment. Kering is due to report Q1 2026 revenue on April 14, followed by a Capital Markets Day on April 16. Both events will test whether management’s recovery story is gaining traction with the market.

Morgan Stanley revised its 2028 EPS estimate down 4% to €15.97, still 15% above Visible Alpha consensus of €13.80. On that figure, the stock trades at roughly 17 times forward earnings.

The bank projects group sales reaching €18.3 billion by 2028, up about 25% from 2025’s €14.7 billion. Consolidated operating margin is expected to expand from 12.5% in 2026 to 18.4% by 2028.

Morgan Stanley’s bull case stands at €480, banking on a Gucci super-cycle and group margins hitting 25.9% in 2028. The bear case is €175, based on the new aesthetic failing to find a commercial audience. Options markets currently price a roughly 28.9% chance the stock tops €320 over the next 12 months, and a 17.1% chance it falls below €175.

The bank flagged two things that could bring it back onside: continued restructuring under CEO Luca de Meo, who took the top job in September 2025, and clearer evidence of a real commercial recovery at Gucci.

Worth noting: Morgan Stanley had upgraded Kering in October 2025, calling it one of its preferred European luxury names and backing the sector’s “burst of creativity.” Monday’s move marks a full reversal of that position.

The post Kering (PRTP) Stock Falls 3% as Morgan Stanley’s Patience With Gucci Runs Out appeared first on CoinCentral.

Market Opportunity
Lorenzo Protocol Logo
Lorenzo Protocol Price(BANK)
$0.0364
$0.0364$0.0364
-1.46%
USD
Lorenzo Protocol (BANK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!